´àÐÔXÖÇÁ¦µÍϵ°°×µ÷½ÚÉñ¾ÔªÖáÍ»·¢ÓýµÄÑо¿Ð½øÕ¹
´àÐÔXȾɫÌå×ÛºÏÖ¢(Fragile X syndrome, FXS)Êdz£¼ûµÄÒÅ´«ÐÔÖÇÁ¦Õϰ¼²²¡£¬ÓÉ´àÐÔXÖÇÁ¦µÍϵ°°×(Fragile X mental retardation protein£¬FMRp)¹¦ÄÜȱʧËùÒýÆð¡£FMRp×÷ΪRNA½áºÏµ°°×£¬Äܹ»Óë´óÁ¿µÄÉñ¾·¢ÓýÏà¹Ø»ùÒòµÄmRNAÖ±½Ó½áºÏ²¢µ÷¿Øµ°°×ºÏ³É¼°¹¦ÄÜ£¬½ø¶øÓ°ÏìÉñ¾ÔªÊ÷Í»¼°Ê÷Í»¼¬·¢ÓýºÍÍ»´¥¿ÉËÜÐÔ¡£Ä¿Ç°µÄÑо¿Ìáʾ£¬³¤Á´·Ç±àÂëRNA (Long non-coding RNAs, LncRNAs)µÄ±í´ïÒì³£¿ÉÄÜÊÇFXSµÄÖ²¡ÒòËØÖ®Ò»¡£È»¶ø£¬FMRpÓëLncRNAsµÄ»¥×÷ÔÚÉñ¾·¢ÓýÖеÄ×÷ÓÃÈÔ²»Çå³þ¡£
Öйú¿ÆÑ§ÔºÒÅ´«Óë·¢ÓýÉúÎïѧÑо¿Ëù¹ùΰÏèÑо¿×éÕë¶ÔFMRpÓëLncRNA Tug1ÔÚÉñ¾ÔªÖáÍ»·¢ÓýÖеŦÄÜÕ¹¿ªÑо¿¡£ÔÚFMpRÇóýСÊóµÄ´óÄÔÖУ¬LcnRNA TUG1µÄ±í´ïˮƽÏÔÖøÉϵ÷¡£RNA-immunoprecipitationʵÑé½á¹ûÖ¤Ã÷FMRpÄܹ»ÓëTUG1»¥×÷²¢½µµÍÆäÎȶ¨ÐÔ£¬ÌáʾFMRpͨ¹ýÖ±½Ó½áºÏ²¢¸ºÏòµ÷¿ØTUG1µÄ±í´ï¡£ÔÚÉñ¾Ôª¹ý±í´ïTUG1µ¼ÖÂÉñ¾ÔªµÄÖáÍ»³¤¶ÈϽµ£¬¶øÊ÷Í»µÄ³¤¶ÈÓ븴Ôӳ̶Èû·¢Éú±ä»¯£¬±íÃ÷TUG1Äܹ»ÌØÒìÐÔµ÷¿ØÉñ¾ÔªÖáÍ»·¢Óý¡£Í¬Ê±£¬ÔÚFMRpȱʧµÄÉñ¾ÔªÖÐÇüõTUG1µÄ±í´ïˮƽÄܹ»²¹¾ÈFMRpϵ÷µ¼ÖµÄÖáÍ»·¢ÓýȱÏÝ¡£
½øÒ»²½Ñо¿·¢ÏÖ£¬TUG1Äܹ»Óëת¼µ÷¿ØÒò×ÓSnoNÖ±½Ó½áºÏÒÖÖÆÆäת¼»îÐÔ£¬¶øÇüõFMRp¼°¹ý±í´ïTUG1¶¼Äܹ»ÏÔÖø½µµÍSnoNÏÂÓΰÐÏò»ùÒòCcd1µÄ±í´ïˮƽ¡£Ccd1¹ý±í´ïÄܹ»»Ö¸´FMRpȱʧ»òÕßTUG1Éϵ÷µÄÉñ¾ÔªµÄÖáÍ»³¤¶È£¬Ö¤ÊµFMRpÓëLncRNA TUG1Ïà½áºÏͨSnoN-Ccd1ÐźÅͨ·µ÷½ÚÉñ¾ÔªÖáÍ»·¢Óý¡£
¸ÃÑо¿ÓÚ2017Äê12ÔÂ1ÈÕ·¢±íÓÚHuman Molecular GeneticsÔÓÖ¾ÉÏ£¨DOI:10.1093/hmg/ddx417£©£¬ÎÄÕÂÌâĿΪ¡±Interplay between FMRp and lncRNA TUG1 regulates axonal development through mediating SnoN-Ccd1 pathway¡±¡£¹ùΰÏèÑо¿×鲩ʿºó¹ùÒ°ºÍÒѱÏҵ˶ʿÑо¿Éú³ÂÐñΪ±¾ÎĵĹ²Í¬µÚÒ»×÷Õߣ¬¶«±±Ê¦·¶´óѧÖìóã¾ê½ÌÊÚʵÑéÊÒÔÚʵÑé¹ý³ÌÖÐÌṩÁËÖØÒª°ïÖú¡£¸ÃÑо¿Êܵ½Á˹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¡¢ÖпÆÔºÇ°ÑØ¿ÆÑ§ÖصãÑо¿¼Æ»®¡¢±±¾©ÄԼƻ®¼°****µÄ×ÊÖú¡£
ÔÎıêÌ⣺
Interplay between FMRp and lncRNA TUG1 regulates axonal development through mediating SnoN-Ccd1 pathway